Clinical trial
AI-human Collaborative Diagnosis of Liver Tumors Using CE-CT
NCT07153783 is registered in ClinicalTrials.gov with Shengjing Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AI-human Collaborative Diagnosis of Liver Tumors Using CE-CT
- Lead sponsor
- Shengjing Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 1, 2025
- Completion date
- November 7, 2025
- Enrollment
- 10,333 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cyst, focal nodular hyperplasia, hepatic hemangioma, hepatic metastasis, hepatocellular carcinoma (hcc), intrahepatic cholangiocarcinoma (icc)